Nephro Care India Limited, provides treatment for kidney-related diseases in India. The company offers care for renal failure patients that include consultation, treatment, and yoga; nutritional support, including nutritional support for weight loss/weight gain, body composition analysis, anthropometry, and lifestyle education and support services for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, lupus nephropathy, and ADPKD; and lifestyle and rehabilitation programs. Its clinics provides renal transplant, urology, vascular surgery, carepath diagnostics, digital radiology, cardiology, OT facilities, women welfare services. In addition, the company offers pulmonary function test, EMG/NCV-testing, uroflowmetry, EEG, polysomnography, and retinal screening services. The company was incorporated in 2014 and is based in Kolkata, India.
| Current Price | ₹85.00 |
|---|---|
| Market Cap | ₹142 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 41.7 |
| 52-Week Range | ₹50.05 – ₹156.35 |
| Beta (1Y) | 1.23 |
| Revenue | ₹29 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| EPS (Basic) | ₹0.98 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Healthcare Facilities & Services-100%
Nephro Care India Limited is trading at ₹85.00, with a market capitalisation of ₹142 Cr.
Nephro Care India Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Nephro Care India Limited has a P/E of 41.7.
In Q1 FY27, Nephro Care India Limited reported revenue of ₹29 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.98 (consolidated, parsed from the company's exchange filing).